Blocking IL-22 signaling resulted in unfavourable effects on body weight, glucose tolerance and insulin sensitivity [4], whereas treatment with recombinant IL-22 proteins or IL-22 overexpression counteracted weight increase and improved hyperglycaemia, insulin resistance and inflammation [4, 5, 22]. This evidence concerns the gene IL22 and Insulin resistance.